We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794

Top Buys

Rank Stock Value
1
OEF icon
iShares S&P 100 ETF
OEF
+$2.43B
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$1.24B
3
DFAI
Dimensional International Core Equity Market ETF
DFAI
+$202M
4
KORP icon
American Century Diversified Corporate Bond ETF
KORP
+$152M
5
VSS icon
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
+$144M

Top Sells

Rank Stock Value
1
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$91.2M
2
VTV icon
Vanguard Morningstar Value ETF
VTV
+$62.6M
3
AXON
Axon Enterprise
AXON
+$58.1M
4
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$46.5M
5
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FEMS icon
201
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$237M
$5.73M 0.08%
129,264
+4,894
+4% +$209K
TMO icon
202
Thermo Fisher Scientific
TMO
$214B
$5.68M 0.08%
11,711
+9,046
+339% +$4.21M
NBIX icon
203
Neurocrine Biosciences
NBIX
$18.2B
$5.66M 0.08%
40,334
+40,209
+32,167% +$5.45M
BMRN icon
204
BioMarin Pharmaceuticals
BMRN
$11.9B
$5.6M 0.08%
103,334
+103,251
+124,399% +$5.9M
ELV icon
205
Elevance Health
ELV
$81.5B
$5.56M 0.08%
17,207
+15,726
+1,062% +$4.89M
ZBRA icon
206
Zebra Technologies
ZBRA
$13.5B
$5.56M 0.08%
18,709
+17,428
+1,360% +$5.57M
GRMN
207
Garmin
GRMN
$56.9B
$5.53M 0.08%
22,452
+22,066
+5,717% +$5.09M
VRT icon
208
Vertiv
VRT
$85.9B
$5.5M 0.08%
36,480
+33,592
+1,163% +$4.48M
AMAT icon
209
Applied Materials
AMAT
$347B
$5.48M 0.08%
26,789
+23,528
+721% +$4.27M
EVR icon
210
Evercore
EVR
$11.8B
$5.47M 0.08%
16,203
+16,014
+8,473% +$5.02M
NFLX icon
211
Netflix
NFLX
$307B
$5.43M 0.08%
45,290
+11,000
+32% +$1.34M
JCI icon
212
Johnson Controls International
JCI
$85.1B
$5.42M 0.08%
49,320
+45,814
+1,307% +$4.9M
PB icon
213
Prosperity Bancshares
PB
$8.9B
$5.41M 0.08%
81,487
+80,866
+13,022% +$5.56M
TMUS icon
214
T-Mobile US
TMUS
$195B
$5.31M 0.08%
22,198
+20,240
+1,034% +$4.9M
REGN icon
215
Regeneron Pharmaceuticals
REGN
$72.9B
$5.31M 0.08%
9,442
+9,361
+11,557% +$5.29M
IQV icon
216
IQVIA
IQV
$40.7B
$5.31M 0.08%
27,947
+26,235
+1,532% +$4.77M
ROP icon
217
Roper Technologies
ROP
$40.4B
$5.3M 0.08%
10,617
+8,257
+350% +$4.4M
ULTA icon
218
Ulta Beauty
ULTA
$21.8B
$5.29M 0.08%
9,672
+9,499
+5,491% +$4.87M
NWSA icon
219
News Corp Class A
NWSA
$15.6B
$5.29M 0.08%
171,979
+170,655
+12,889% +$5.06M
MDB icon
220
MongoDB
MDB
$25.8B
$5.24M 0.08%
16,890
+16,622
+6,202% +$4.27M
USB icon
221
US Bancorp
USB
$97.9B
$5.22M 0.07%
108,000
+102,115
+1,735% +$4.83M
AMD icon
222
Advanced Micro Devices
AMD
$700B
$5.22M 0.07%
32,246
+28,307
+719% +$4.57M
TXRH icon
223
Texas Roadhouse
TXRH
$13.7B
$5.16M 0.07%
31,081
+31,019
+50,031% +$5.47M
NNN icon
224
NNN REIT
NNN
$9.29B
$5.1M 0.07%
119,741
+118,322
+8,338% +$5.02M
THC icon
225
Tenet Healthcare
THC
$22.2B
$5.09M 0.07%
25,089
+24,224
+2,800% +$4.3M
7 8
9
10 11

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
WWA
WCG Wealth Advisors Las Vegas, Nevada $3.57B AUM 18.63% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BPS
BNDES Participacoes SA Rio De Janeiro, Brazil $3.58B AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.